Agenda: Day 1

All session times are in Eastern Time (ET)

There are no agenda items with this track

8:00 am

8:00 am

Registration & Breakfast

  • Start your day off right and make connections with market access leaders
  • Interact with your peers, discuss best practices and share innovative strategies
  • Gather essential content and get exclusive offers at exhibit booths

9:00 am

9:00 am

Welcome From The Chair

Gain insight into today’s sessions so you can get the most out of your experience and maximize your value.

9:15 am

9:15 am

OPENING KEYNOTE: CANADIAN HEALTHCARE LANDSCAPE

CANADA’S HEALTHCARE SYSTEM – NOT AS BAD AS WE THINK (BUT NOT QUITE AS GOOD EITHER)

Not taking a page out of the COVID-19 playbook, the federal government and Canada’s 13 premiers are back to squabbling over healthcare funding. Meanwhile Canadians feel under-served for their tax dollars, and are fed up with temporary closures of ER’s and consistent staffing issues in all facets of healthcare. Exchange ideas and perspectives with one of Canada’s most respected – and always controversial – healthcare critics on topics including:

  • where does the future of healthcare funding lie
  • what can we as an industry do to increase Canadians’ access to new drugs
  • how can we make the healthcare sector more attractive for GenZ

Share your point of view and bring back actionable ideas to your senior management

10:00 am

10:00 am

FIRESIDE CHAT: CADTH UPDATE

Are We Increasing The Percentage Of Submissions Approved First Time Around, or Not?

How much time in spent revising new drug submissions when you add it all up? Accurately interpreting the impact of these learnings is fundamental to your company’s bottom line. Source intelligence to:

  • Gain a comprehensive understanding of the information requirements for drug submissions to CADTH
  • Adopt best practices to better manage your product submissions under the revised process
  • Navigate through the changes seamlessly and efficiently

Position your product for a prosperous journey through the updated CADTH review process

10:30 am

10:30 am

Morning Break

  • Engage with conference speakers and fellow attendees
  • Secure new business contacts and discuss crucial developments in market access
  • Exchange innovations and ideas

11:00 am

11:00 am

STOPPING THE BRAIN DRAIN

Of the 20 leading and emerging fintech hubs globally, Toronto ranked #8, Vancouver #12, Montreal #14 and Calgary #16. Unpack why the same can’t be said for Canada’s health and life sciences sector, and outline what can be done to change that. Take back strategies to galvanize your senior management (and MP) to build a resilient industry by:

  • Using the economic drivers of biotech and fintech as prime examples of successful strategy execution
  • Leveraging learning from key players
  • Incorporating government departmental mandates to strengthen the case for the benefit of all

11:30 am

11:30 am

PMPRB ’22 GUIDELINES – WHAT DO WE KNOW SO FAR? SPECIAL Q&A

The PMPRB released its revised draft Guidelines on October 6th, making big news for the industry! Gain a better understanding of the details to prepare your senior management team both in Canada and internationally. Take away new perspectives and deepen your knowledge on:

  • How the guidelines have been ‘updated’ given previous litigation
  • Is what was formerly a ‘competition bureau’ approach applicable to drug pricing?
  • What does TRUE access mean?
  • Which arguments are acceptable in the face of future manufacturer investigations?

Set yourself up for success with answers to your toughest PMPRB questions.

12:30 pm

12:30 pm

Networking Lunch

  • Expand your network and make connections that last beyond the event
  • Visit the exhibitor hall and pose your toughest questions to leading consultants
  • Enjoy great food and service while engaging with your pharma colleagues

2:00 pm

2:00 pm

INDUSTRY EXPERT - PDCI

TO LAUNCH OR NOT TO LAUNCH, THAT IS THE QUESTION!

Canada ranks 10th out of 14 countries on its attractiveness for new medicine launch according to PDCI’s 2022 Biopharmaceutical Ecosystem Index. To ensure Canadian patients gain access to the new medicines of the future, we must keep pace with how constantly evolving local and international market access landscapes will affect Canada’s relative attractiveness for launch in the years to come. Develop your advocacy plan by:

  • Learning how Canada currently stacks up on its Development & Commercialization Infrastructure, Regulatory Landscape, and Market Access Environment
  • Identifying the policy areas that could most effectively improve our relative attractiveness
  • Discussing what Canada’s attractiveness rankings mean to Canadian patients

Share perspectives with your senior management that can help make a difference in future new drug launches

3:00 pm

3:00 pm

PANEL DISCUSSION: DRUGS FOR RARE DISEASES

Critical Elements for a National Strategy and Framework

With Health Canada preparing for the development and implementation of a national strategy for high-cost drugs for rare diseases, what can we learn from the COVID-19 vaccine journey? Leverage the experience of these market leaders to inform your market access strategy. Establish your game plan by:

  • Determining the types of partnerships and funding that will be key to the successful development of drugs for rare diseases
  • Analyzing the impact of recently increased government funding on the overall treatment pipeline
  • Visualizing potential safe and expeditious routes to commercialization for these medicines 

Chart a course to succeed in the new market access model for rare disease therapies

4:00 pm

4:00 pm

AFTERNOON BREAK

4:50 pm

4:50 pm

Day One: Summary and Closing Comments from your Host

Review the key solutions and takeaways from today’s sessions. Source a summary of action points to implement in your work. Discuss tomorrow’s highlights!

5:00 pm

5:00 pm

Evening Reception

Don’t miss this chance to connect with speakers, attendees and sponsors! Unwind, mingle and build relationships that will benefit you in the years to come.

Get the latest news

*Privacy Policy